Wells Fargo’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,157
| Closed | -$39.8K | – | 7131 |
|
|
2024
Q2 | $39.8K | Buy |
7,157
+6,870
| +2,394% | +$24.4K | ﹤0.01% | 5383 |
|
|
2024
Q1 | $1.12K | Buy |
287
+5
| +2% | +$19 | ﹤0.01% | 6126 |
|
|
2023
Q4 | $1.22K | Buy |
282
+243
| +623% | +$821 | ﹤0.01% | 6183 |
|
|
2023
Q3 | $121 | Sell |
39
-4
| -9% | -$13 | ﹤0.01% | 6719 |
|
|
2023
Q2 | $126 | Buy |
43
+4
| +10% | +$9 | ﹤0.01% | 6822 |
|
|
2023
Q1 | $82 | Buy |
39
+1
| +3% | +$2 | ﹤0.01% | 6980 |
|
|
2022
Q4 | $103 | Buy |
38
+1
| +3% | +$4 | ﹤0.01% | 6784 |
|
|
2022
Q3 | $0 | Buy |
37
+7
| +23% | +$43 | ﹤0.01% | 7588 |
|
|
2022
Q2 | $0 | Buy |
30
+3
| +11% | +$17 | ﹤0.01% | 7699 |
|
|
2022
Q1 | $0 | Hold |
27
| – | – | ﹤0.01% | 8032 |
|
|
2021
Q4 | $0 | Hold |
27
| – | – | ﹤0.01% | 7985 |
|
|
2021
Q3 | $0 | Hold |
27
| – | – | ﹤0.01% | 7678 |
|
|
2021
Q2 | $0 | Hold |
27
| – | – | ﹤0.01% | 7612 |
|
|
2021
Q1 | $0 | Buy |
27
+5
| +23% | +$41 | ﹤0.01% | 7537 |
|
|
2020
Q4 | $0 | Hold |
22
| – | – | ﹤0.01% | 7167 |
|
|
2020
Q3 | $0 | Sell |
22
-7
| -24% | -$41 | ﹤0.01% | 7057 |
|
|
2020
Q2 | $0 | Hold |
29
| – | – | ﹤0.01% | 6966 |
|
|
2020
Q1 | $0 | Buy |
+29
| New | +$177 | ﹤0.01% | 6965 |
|
|
2019
Q1 | – | Sell |
-900
| Closed | -$10K | – | 6548 |
|
|
2018
Q4 | $10K | Hold |
900
| – | – | ﹤0.01% | 5937 |
|
|
2018
Q3 | $13K | Hold |
900
| – | – | ﹤0.01% | 5939 |
|
|
2018
Q2 | $13K | Buy |
+900
| New | +$12.7K | ﹤0.01% | 5908 |
|
|
2016
Q2 | – | Sell |
-158
| Closed | -$4K | – | 6379 |
|
|
2016
Q1 | $4K | Buy |
158
+89
| +129% | +$2.77K | ﹤0.01% | 5926 |
|
|
2015
Q4 | $3K | Sell |
69
-64
| -48% | -$2.78K | ﹤0.01% | 5982 |
|
|
2015
Q3 | $4K | Buy |
133
+15
| +13% | +$845 | ﹤0.01% | 5903 |
|
|
2015
Q2 | $8K | Buy |
118
+3
| +3% | +$207 | ﹤0.01% | 5883 |
|
|
2015
Q1 | $9K | Buy |
115
+15
| +15% | +$1.18K | ﹤0.01% | 5668 |
|
|
2014
Q4 | $8K | Buy |
100
+20
| +25% | +$1.62K | ﹤0.01% | 5728 |
|
|
2014
Q3 | $7K | Sell |
80
-44
| -35% | -$3.76K | ﹤0.01% | 5737 |
|
|
2014
Q2 | $11K | Buy |
124
+123
| +12,300% | +$10.9K | ﹤0.01% | 5611 |
|
|
2014
Q1 | $0 | Sell |
1
-132
| -99% | -$12.8K | ﹤0.01% | 6120 |
|
|
2013
Q4 | $9K | Buy |
+133
| New | +$5.42K | ﹤0.01% | 5226 |
|
Wells Fargo's ALIM Position: Q3 2024 in Review
Wells Fargo sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 7,157 shares — an estimated $39.8K sold.
Wells Fargo first reported a position in ALIM in Q4 2013 and held it in 31 quarters. The position peaked at $39.8K in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- Wells Fargo reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- Wells Fargo sold 7,157 Alimera Sciences shares in Q3 2024, an estimated $39.8K.
- Wells Fargo first reported a position in Alimera Sciences in Q4 2013 and held it in 31 quarters.
- Wells Fargo's Alimera Sciences position peaked at $39.8K in Q2 2024.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on Wells Fargo's 13F filing for Q3 2024, filed 13 Nov 2024.